These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9923789)

  • 1. Prednisone is more effective than prednisolone metasulfobenzoate in the treatment of bullous pemphigoid.
    Lebrun-Vignes B; Roujeau JC; Bernard P; Delaporte E; Joly P; Prost C; Vaillant L; Herson S; Chosidow O
    Arch Dermatol; 1999 Jan; 135(1):89-90. PubMed ID: 9923789
    [No Abstract]   [Full Text] [Related]  

  • 2. Chlorambucil as a steroid-sparing agent in bullous pemphigoid.
    Chave TA; Mortimer NJ; Shah DS; Hutchinson PE
    Br J Dermatol; 2004 Nov; 151(5):1107-8. PubMed ID: 15541099
    [No Abstract]   [Full Text] [Related]  

  • 3. Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial.
    Williams HC; Wojnarowska F; Kirtschig G; Mason J; Godec TR; Schmidt E; Chalmers JR; Childs M; Walton S; Harman K; Chapman A; Whitham D; Nunn AJ;
    Lancet; 2017 Apr; 389(10079):1630-1638. PubMed ID: 28279484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for bullous pemphigoid.
    Khumalo N; Kirtschig G; Middleton P; Hollis S; Wojnarowska F; Murrell D
    Cochrane Database Syst Rev; 2003; (3):CD002292. PubMed ID: 12917929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Methylprednisolone versus prednisolone methylsulfobenzoate in pemphigoid: a comparative multicenter study].
    Dreno B; Sassolas B; Lacour P; Montpoint S; Lota I; Giordano F; Royer P
    Ann Dermatol Venereol; 1993; 120(8):518-21. PubMed ID: 8304707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of pemphigoid nodularis after remission of bullous lesions.
    Hattori M; Shimizu A; Ishikawa O
    Clin Exp Dermatol; 2019 Mar; 44(2):e1-e2. PubMed ID: 30242789
    [No Abstract]   [Full Text] [Related]  

  • 7. Dyshidrosiform bullous pemphigoid.
    Kim YJ; Kim MY; Kim HO; Park YM
    Acta Derm Venereol; 2004; 84(3):253-4. PubMed ID: 15202856
    [No Abstract]   [Full Text] [Related]  

  • 8. A retrospective analysis of patients with bullous pemphigoid treated with methotrexate.
    Kjellman P; Eriksson H; Berg P
    Arch Dermatol; 2008 May; 144(5):612-6. PubMed ID: 18490587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between effective dose of prednisolone, alone or in conjunction with other immunosuppressants, and titre of anti-bullous pemphigoid 180 antibody: a retrospective study of 42 cases.
    Miida H; Fujiwara H; Ito M
    Clin Exp Dermatol; 2011 Jul; 36(5):485-8. PubMed ID: 21392080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy of prednisolone and i.v. immunoglobulin treatment decreases circulating interleukin-5 and eosinophils in a patient with bullous pemphigoid.
    Yamashita C; Nakamizo S; Honda Y; Dainichi T; Kabashima K
    J Dermatol; 2017 Jan; 44(1):101-102. PubMed ID: 27154738
    [No Abstract]   [Full Text] [Related]  

  • 11. Simultaneous occurrence of pemphigus foliaceus and bullous pemphigoid with concomitant herpesvirus infection.
    Lin SS; Wang KH; Yeh SW; Chen WY; Tsai TH
    Clin Exp Dermatol; 2009 Jun; 34(4):537-9. PubMed ID: 19236424
    [No Abstract]   [Full Text] [Related]  

  • 12. Bilateral inguinal scrofuloderma during steroid therapy in a patient with bullous pemphigoid.
    Kawabata E; Morita K; Matsuyoshi N; Ohta K; Okamoto H; Ikai K; Imamura S
    J Dermatol; 1995 Aug; 22(8):582-6. PubMed ID: 7560456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyodermatitis vegetans with antibodies to bullous pemphigoid antigen 180.
    Kawahira H; Higashi Y; Matsuoka A; Fujii K; Ishii N; Hashimoto T; Kanekura T
    J Dermatol; 2017 Dec; 44(12):1417-1418. PubMed ID: 27914095
    [No Abstract]   [Full Text] [Related]  

  • 14. A systematic review of treatments for bullous pemphigoid.
    Khumalo NP; Murrell DF; Wojnarowska F; Kirtschig G
    Arch Dermatol; 2002 Mar; 138(3):385-9. PubMed ID: 11902990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective study of 60 hospitalized cases with pemphigoid.
    Baoxi W; Xiuqing D; Ying Z; Jiabi W
    Chin Med Sci J; 2000 Jun; 15(2):127-8. PubMed ID: 12901642
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term oral prednisolone exposure in primary care for bullous pemphigoid: population-based study.
    Persson MS; Harman KE; Thomas KS; Chalmers JR; Vinogradova Y; Langan SM; Hippisley-Cox J; Gran S
    Br J Gen Pract; 2021 Dec; 71(713):e904-e911. PubMed ID: 34607796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case of bullous pemphigoid accompanied by collagenous gastroenteritis.
    Shiba-Tokuchi K; Moriuchi R; Morita Y; Takashima Y; Shirato T; Koike Y; Izumi K; Nishie W; Shimizu S
    J Dermatol; 2017 Dec; 44(12):e365-e366. PubMed ID: 28862318
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of bullous pemphigoid with enteric-coated mycophenolate sodium.
    Tursen U; Guney A; Kaya T; Ikizoglu G
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):542-4. PubMed ID: 17373988
    [No Abstract]   [Full Text] [Related]  

  • 19. Spectrum of Clinical Responses to Therapies in Infantile Bullous Pemphigoid.
    Taquin H; Chiaverini C; Lacour JP
    Pediatr Dermatol; 2016; 33(2):e77-81. PubMed ID: 26764161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-p200 pemphigoid in a 17-year-old girl successfully treated with systemic corticosteroid and dapsone.
    Yamane N; Sawamura D; Nishie W; Abe M; Kodama K; Adachi K; Nakamura H; Ishii N; Hashimoto T; Shimizu H
    Br J Dermatol; 2007 May; 156(5):1075-8. PubMed ID: 17381449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.